FindTrial
Sign In

A clinical study to compare the treatment response in asthmatic children between 5 to 15 years of age via Metered dose inhaler with spacer Vs Nebuliser

A Randomized control study on comparison of Metered dose Inhaler with spacer Vs Nebuliser in Paediatric Acute exacerbation of Asthma aged between 5 TO 15 Years

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/03/023829
Enrollment
58
Registered
2020-03-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J459- Other and unspecified asthma

Interventions

Intervention1: Non inferiority comparison of treatment response with Levosalbutamol between 2 groups of acute exacerbation of paediatric Asthma: children between 5 to 15 years with Acute exacerbation

Sponsors

Dr Arunprasath P
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Mild to Moderate Asthmatic children aged between 5 to 15 years,as per GINA Guidelines 2018 updates

Exclusion criteria

Exclusion criteria: Severe asthmatic children aged between 5 to 15 years ,as per GINA guidelines 2018 updates

Design outcomes

Primary

MeasureTime frame
After treatment with Levosalbutamol via metered dose inhaler with spacer Vs Nebuliser,Reassess the children after 1 hour based on Pulmonary Index Score(Respiratory Rate,Wheezing,Inspiratory And Expiratory Ratio,Use of Accessory Muscle,Oxygen saturation)Timepoint: 1 Years—

Secondary

MeasureTime frame
During Reassessment after 1 hour of treatment,Look for whether the child discharged as outpatient,admitted in ward or admitted at paediatric ICUTimepoint: variable—

Countries

India

Contacts

Public ContactDr E Bharathi

The Tamilnadu Dr MGR Medical university

drjayavardhana@gmail.com9944469902

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026